ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LICN vs PG // FORWARD P/E MULTIPLE

Lichen International Limited (Class A) (NASDAQ) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: LICN 1 — PG 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LICN VS. PG) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LICN PG SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 96.00% 51.20% +44.80 LICN /gross-margins <GO>
Return on Invested Capital (ROIC) -32.70% 25.40% -58.10 PG /roic <GO>
EV/EBITDA & P/E Valuation — 16.2x — TIE /valuation <GO>
Free Cash Flow Yield — 3.77% — TIE /fcf-yield <GO>
Operating Margin -60.00% 24.30% -84.30 PG /operating-margins <GO>
Net Profit Margin -60.00% 19.00% -79.00 PG /net-margins <GO>
Revenue Growth (YoY) — 0.30% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.65% -2.65 PG /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.57 5.59 -4.02 PG /balance-sheet <GO>
Piotroski F-Score Quality 3/9 7/9 -4.00 PG /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 26.5 60.3 -33.82 PG /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.87 — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — 21.7x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $12.3M $372.21B -$372.20B PG /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LICN REV PG REV LICN GROSS % PG GROSS % LICN FCF PG FCF
FY 2025 $809.0K $84.28B 98.0% 51.2% -$17.8M $14.04B
FY 2024 $0 $84.04B — 51.4% -$5.6M $16.52B
FY 2023 $0 $82.01B — — $557.0K $13.16B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LICN // BETA —
PG // BETA 0.87